Bayesian Capital Management, LP Twist Bioscience Corp Transaction History

Bayesian Capital Management, LP

  • $838 Million
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$27.95 - $53.0 $176,085 - $333,900
6,300 Added 43.31%
20,846 $1.03 Million
Q1 2024

May 15, 2024
BUY
$32.28 - $41.5 $140,482 - $180,608
4,352 Added 42.69%
14,546 $499,000
Q4 2023

Feb 14, 2024
BUY
$15.08 - $38.61 $153,725 - $393,590
10,194 New
10,194 $375,000
Q4 2022

Feb 14, 2023
BUY
$21.92 - $39.37 $437,852 - $786,415
19,975 New
19,975 $475,000
Q2 2022

Aug 15, 2022
SELL
$26.2 - $54.0 $230,560 - $475,200
-8,800 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$38.58 - $83.27 $339,504 - $732,776
8,800 New
8,800 $435,000

Others Institutions Holding TWST

# of Institutions
256
Shares Held
66.8M
Call Options Held
127K
Put Options Held
45.4K
View Full List

About Twist Bioscience Corp

TWST Quotes by TradingView
  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.32B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email